334 related articles for article (PubMed ID: 11929045)
1. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
[TBL] [Abstract][Full Text] [Related]
2. [Are the hemochromatosis (HFE) gene mutation and hepatitis C virus (HCV) infection risk factors for porphyria cutanea tarda?].
Nagy Z; Kószó F; Pár A; Nagy A; Horányi M; Morvay M; Dobozy A; Mózsik G
Orv Hetil; 2000 Sep; 141(37):2031-4. PubMed ID: 11037612
[TBL] [Abstract][Full Text] [Related]
3. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
[TBL] [Abstract][Full Text] [Related]
4. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
[TBL] [Abstract][Full Text] [Related]
5. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
6. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis C, hemochromatosis and porphyria cutanea tarda].
Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U
Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178
[TBL] [Abstract][Full Text] [Related]
8. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
Pedersen P; Milman N
Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
[TBL] [Abstract][Full Text] [Related]
9. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP
Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077
[TBL] [Abstract][Full Text] [Related]
10. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
Stuart KA; Busfield F; Jazwinska EC; Gibson P; Butterworth LA; Cooksley WG; Powell LW; Crawford DH
J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
[TBL] [Abstract][Full Text] [Related]
11. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
Tannapfel A; Stölzel U; Köstler E; Melz S; Richter M; Keim V; Schuppan D; Wittekind C
Virchows Arch; 2001 Jul; 439(1):1-5. PubMed ID: 11499833
[TBL] [Abstract][Full Text] [Related]
12. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.
Méndez M; Poblete-Gutiérrez P; García-Bravo M; Wiederholt T; Morán-Jiménez MJ; Merk HF; Garrido-Astray MC; Frank J; Fontanellas A; Enríquez de Salamanca R
Br J Dermatol; 2007 Sep; 157(3):501-7. PubMed ID: 17627795
[TBL] [Abstract][Full Text] [Related]
16. Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Sinclair JF; Gerhard GS; Szakacs JG; Andrews NC; Levy JE
Hepatology; 2001 Feb; 33(2):406-12. PubMed ID: 11172342
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
18. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
Brady JJ; Jackson HA; Roberts AG; Morgan RR; Whatley SD; Rowlands GL; Darby C; Shudell E; Watson R; Paiker J; Worwood MW; Elder GH
J Invest Dermatol; 2000 Nov; 115(5):868-74. PubMed ID: 11069625
[TBL] [Abstract][Full Text] [Related]
19. The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda.
Roberts AG; Whatley SD; Nicklin S; Worwood M; Pointon JJ; Stone C; Elder GH
Hepatology; 1997 Jan; 25(1):159-61. PubMed ID: 8985283
[TBL] [Abstract][Full Text] [Related]
20. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]